FOSPROPOFOL DISODIUM FOR SEDATION

被引:1
作者
Campion, Megan E. [1 ]
Gan, Tong J. [1 ]
机构
[1] Duke Univ, Med Ctr, Dept Anesthesiol, Durham, NC 27710 USA
关键词
SEE VOL. 112; WATER-SOLUBLE PRODRUG; MODERATE SEDATION; PG; 1058; DOUBLE-BLIND; GPI; 15715; CONSCIOUS SEDATION; BOLUS INJECTION; PROPOFOL; PHARMACOKINETICS;
D O I
10.1358/dot.2009.45.8.1396674
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The practice of procedural sedation is expanding rapidly because minimally invasive surgery and interventional medical specialties ore replacing conventional surgery, and increasingly these procedures con appropriately be done under sedation rather than general anesthesia. Patients prefer sedation techniques so the procedures con be accomplished with minimal discomfort and they con recover more rapidly and ovoid the potential side effects of general anesthesia. The goals for a sedation technique are to provide sedation, analgesia and, as requested, amnesia. This requires a balance between patient comfort and safety, while preventing cardiovascular or respiratory compromise or delayed recovery. Propofol has been used for over two decades and has many properties ideally suited for procedural sedation. More recently, a new propofol prodrug, fospropofol disodium was also approved in the U.S. as a sedative. Fospropofol is formulated in aqueous solution and has some potential advantages over propofol. This review discusses the pharmacology and clinical uses of propofol and fospropofol, as well as the benefits and disadvantages of the two drugs when used for sedation.
引用
收藏
页码:567 / 576
页数:10
相关论文
共 36 条
[11]  
Fechner J., 2008, V182, P253, DOI 10.1007/978-3-540-74806-9_12
[12]  
GAN TJ, 2009, J CLIN ANES IN PRESS
[13]   Pharmacokinetic and pharmacodynamic characteristics of medications used for moderate sedation [J].
Gan, Tong J. .
CLINICAL PHARMACOKINETICS, 2006, 45 (09) :855-869
[14]   RETRACTED: AQUAVANO® injection, a water-soluble prodrug of propofol, as a bolus injection:: A phase I dose-escalation comparison with DIPRIVAN® (Part 1) -: Pharmacokinetics (Retracted article. See vol. 112, pg. 1058, 2010) [J].
Gibiansky, E ;
Struys, MMRF ;
Gibiansky, L ;
Vanluchene, ALG ;
Vornov, J ;
Mortier, EP ;
Burak, E ;
Van Bortel, L .
ANESTHESIOLOGY, 2005, 103 (04) :718-729
[15]  
Gross JB, 2002, ANESTHESIOLOGY, V96, P1004
[16]   Safety of propofol for conscious sedation during endoscopic procedures in high-risk patients - A prospective, controlled study [J].
Heuss, LT ;
Schnieper, P ;
Drewe, J ;
Pflimlin, E ;
Beglinger, C .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2003, 98 (08) :1751-1757
[17]   Propofol EDTA and reduced incidence of infection [J].
Jansson, J-R. ;
Fukada, T. ;
Ozaki, M. ;
Kimura, S. .
ANAESTHESIA AND INTENSIVE CARE, 2006, 34 (03) :362-368
[18]   Understanding modes of moderate sedation during gastrointestinal procedures: a current review of the literature [J].
Lubarsky, David A. ;
Candiotti, Keith ;
Harris, Eric .
JOURNAL OF CLINICAL ANESTHESIA, 2007, 19 (05) :397-404
[19]   A randomized, open-label, multicenter, dose-ranging study of sedation with aquavan injection (GPI 15715) during colonoscopy [J].
Pruitt, RE ;
Cohen, LB ;
Gibiansky, E ;
Wang, C ;
Strayhorn, S ;
Weinstein, M ;
Katz, S ;
Medoff, JR ;
Schwartz, H ;
Riff, DS ;
Vincek, W ;
Wall, V ;
Enriquez, FJ .
GASTROINTESTINAL ENDOSCOPY, 2005, 61 (05) :AB111-AB111
[20]   Review article: moderate sedation for endoscopy: sedation regimens for non-anaesthesiologists [J].
Rex, D. K. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2006, 24 (02) :163-171